News Articles

Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using... NEUCHATEL, Switzerland -Wednesday 7 April 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated...

Study Investigates the Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with... -Monday 29 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo...

Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using... -Monday 22 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening...

New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With... -Monday 15 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA® Portable Capnograph “useful for...

Masimo Monitoring Solutions Promote Newborn and Maternal Safety -Thursday 11 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET® pulse oximetry’s ability to measure during motion and low perfusion has helped...

Masimo Announces CE Marking of the Rad-G™ with Temperature -Wednesday 3 March 2021  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET® pulse oximetry, respiration rate from the pleth (RRp®), and other important parameters alongside clinical-grade, non-contact...

Researchers Use Masimo ORi™, Oxygen Reserve Index, to Help Suppress Postoperative Hyperoxia in Patients Undergoing... -Monday 14 December 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Kumagai and colleagues at Iwate Medical University Hospital in Yahaba-cho, Japan investigated whether Masimo ORi™, Oxygen Reserve Index, could be used to...

New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient... -Monday 14 December 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Saraçoğlu and colleagues at Marmara University in Istanbul, Turkey investigated the efficacy of Masimo noninvasive and continuous hemoglobin...

Study Comparing Two Noninvasive Indicators of Fluid Responsiveness on Mechanically Ventilated Patients Finds Masimo... -Tuesday 1 December 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Ain-Shams Journal of Anesthesiology in which Dr. Diaaeldin Aboelnile and colleagues at Ain-Shams University in Cairo, Egypt compared two noninvasive methods of assessing fluid responsiveness in...

Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous... -Tuesday 17 November 2020  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the findings of a study published in Blood Transfusion in which Dr. Lucia Merolle and colleagues at the Azienda USL-IRCCS of Reggio Emilia, Italy investigated the impact of applying a patient blood management program, including use of...

Masimo Announces Limited Market Release of Radius VSM™ -Tuesday 3 November 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius VSM™, a wearable, tetherless vital signs monitor, has received CE marking and is being released in limited European markets. The versatile, expandable Radius VSM provides the ability to monitor a wide variety of...

Researchers Use Masimo ORi™, Oxygen Reserve Index, to Predict the Need for Postoperative Oxygen Therapy in... -Monday 12 October 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting of the American Society of Anesthesiologists (ASA). In this independent, retrospective study, researchers investigated whether Masimo ORi™ (Oxygen...

New Studies Investigate the Accuracy of Noninvasive, Continuous Hemoglobin Monitoring with Masimo SpHb® on... -Wednesday 19 August 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced that in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb® (noninvasive, continuous hemoglobin monitoring) on neonatal patients concluded that the technology “offers reliable Hb...

New Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo... -Monday 20 July 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on critical congenital heart disease (CCHD) screening for...

Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo... -Monday 6 July 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to...

Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than Central Venous Pressure Measurement... -Tuesday 5 May 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two methods of intraoperative fluid management during orthopedic spinal surgery, including Masimo PVi®....

Masimo Announces Full Market Release of Masimo SafetyNet™, a Remote Patient Management Solution Designed to Aid... -Monday 13 April 2020  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) announced today the full market release of Masimo SafetyNet™, an innovative, economically scalable cloud-based patient management solution designed to help clinicians care for patients remotely in hospital settings and in non-traditional settings and...

St. Luke’s University Health Network One of the First in the World to Pilot Masimo SafetyNet™, a Remote... -Friday 10 April 2020  

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the network seeks innovative solutions to care for the surge of patients infected...

Masimo and University Hospitals Jointly Announce Masimo SafetyNet™, a New Remote Patient Management Solution... -Friday 27 March 2020  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) and University Hospitals (UH), one of the largest health systems in Northeast Ohio, today jointly announced Masimo SafetyNet™, an innovative, economically scalable patient management system designed to help clinicians care for patients remotely. The...

In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood... -Thursday 26 March 2020  

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow® licenses available for no additional charge to hospitals where rainbow®-ready devices are already in use. The Masimo...